Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Plos One|September 12, 2013
M1 muscarinic receptor activation mediates cell death in M1-HEK293 cellsE Scott Graham, Kerhan K Woo, Miranda Aalderink, et al.
European Journal of Pharmacology|April 1, 2024
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonistsMonica Patel, Xiaoxi Zheng, Luli R Akinfiresoye, et al.
Neuroscience Letters|November 25, 2006
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brainJohn C Ashton, Rosanna M A Rahman, Shiva M Nair, et al.
Methods in Enzymology|July 29, 2017
Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP SignalingMorag R Hunter, David B Finlay, Christa E Macdonald, et al.
British Journal of Pharmacology|November 23, 2021
Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; β-arrestins and GPCR kinasesMonica Patel, Christoph Matti, Natasha L Grimsey, et al.
British Journal of Pharmacology|September 24, 2015
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptorsWilliam J Redmond, Erin E Cawston, Natasha L Grimsey, et al.
Frontiers in Cellular Neuroscience|August 21, 2018
Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of AutismSuzanne Hosie, Daniel T Malone, Stephanie Liu, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2019
Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probesPhillip S Grant, Nils Kahlcke, Karan Govindpani, et al.
Frontiers in Pharmacology|December 8, 2018
Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-TriazinesCaitlin R M Oyagawa, Sara M de la Harpe, Yurii Saroz, et al.
Pageof 13